2020
Systematic review of racial disparities in clozapine prescribing
Williams JC, Harowitz J, Glover J, Tek C, Srihari V. Systematic review of racial disparities in clozapine prescribing. Schizophrenia Research 2020, 224: 11-18. PMID: 33183948, DOI: 10.1016/j.schres.2020.07.023.Peer-Reviewed Original ResearchConceptsMinority patientsSystematic reviewRelevant covariatesRacial disparitiesUnderutilization of clozapineClinician-related factorsPatient-related factorsRacial minority patientsClozapine prescribingClozapine underutilizationHospital stayPrescription ratesAntipsychotic medicationIndependent reviewersEligibility criteriaElectronic databasesDisease severityRelevant studiesPrescribingPatientsInstitution-related factorsWhite counterpartsDirect examinationRacial groupsPossible causes
2019
Predictive validity of conversion from the clinical high risk syndrome to frank psychosis
Yoviene Sykes LA, Ferrara M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woodberry KA, Powers AR, Ponce AN, Cahill JD, Pollard JM, Srihari VH, Woods SW. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis. Schizophrenia Research 2019, 216: 184-191. PMID: 31864837, PMCID: PMC7239715, DOI: 10.1016/j.schres.2019.12.002.Peer-Reviewed Original ResearchConceptsFrank psychosisFirst-episode psychosis patientsOne-yearNorth American Prodromal Longitudinal StudySeverity of illnessClinical high-risk syndromeCurrent antipsychotic medicationsHigh-risk syndromePsychosis risk syndromeClinical high riskPredictive validityFEP casesPrescription ratesAntipsychotic medicationPsychosis patientsRisk syndromePsychosis onsetHigh riskLittle investigative attentionDiagnostic stabilityCHR individualsPsychosis paradigmPsychosisLongitudinal studySyndrome